The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14612545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumors and inflammatory infiltrates: Friends or foes?

  2004cited by this paper
• Human MCAF Gene Transfer Enhances the Metastatic Capacity of a Mouse Cachectic Adenocarcinoma Cell Line in Vivo

  2004cited by this paper
• Prognostic factors in the palliation of pancreatic cancer.

  2003cited by this paper
• Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• The Role of Oxygen-Derived Free Radicals and Nitric Oxide in Cytokine-Induced Antiproliferation of Pancreatic Cancer Cells

  2002cited by this paper
• Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.

  2002cited by this paper
• Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.

  2002cited by this paper
• Profile of Monocyte Chemoattractant Protein-1 Circulating Levels in Gastric Cancer Patients

  2002cited by this paper
• Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.

  2002cited by this paper
• Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines

  2002cited by this paper
• Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer

  2002cited by this paper
• Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.

  2002cited by this paper
• Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

  2002cited by this paper
• Inflammation and the development of pancreatic cancer.

  2002cited by this paper
• Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer.

  2002cited by this paper
• New applications of gemcitabine and future directions in the management of pancreatic cancer

  2002cited by this paper
• Interleukin-8 and human cancer biology.

  2001cited by this paper
• Regulation of Interleukin-8 Expression by Nitric Oxide in Human Pancreatic Adenocarcinoma

  2001cited by this paper
• Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis

  2001cited by this paper
• Growth factors and their receptors in pancreatic cancer.

  2001cited by this paper
• Ligation of the Fas antigen stimulates chemokine secretion in pancreatic cancer cell line PANC-1.

  2001influential reference
• The expression of chemokine genes correlates with nuclear factor-κB activation in human pancreatic cancer cell lines

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1

  2001cited by this paper
• Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer

  2001cited by this paper
• Regulation of Interleukin-8 Expression by Cellular pH in Human Pancreatic Adenocarcinoma Cells

  2000cited by this paper
• A multispecialty approach to the diagnosis and management of pancreatic cancer

  2000cited by this paper
• Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy

  2000cited by this paper
• Cytokine Production by CAPAN-1 and CAPAN-2 Cell Lines

  2000cited by this paper
• The Expression of Chemokine Genes Correlates with Nuclear Factor-&kgr;B Activation in Human Pancreatic Cancer Cell Lines

  2000cited by this paper
• Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability

  2000cited by this paper
• Current Approaches and Future Strategies for Pancreatic Carcinoma

  2000cited by this paper
• Autocrine Growth Effect of IL-8 and GRO&agr; on a Human Pancreatic Cancer Cell Line, Capan-1

  2000cited by this paper
• Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.

  2000cited by this paper
• Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

  2000cited by this paper
• Current approaches and future strategies for pancreatic carcinoma.

  2000cited by this paper
• Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.

  2000cited by this paper
• Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic Adenocarcinoma

  2000cited by this paper
• Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1

  1999cited by this paper
• Chemokines. Introduction and overview.

  1999cited by this paper
• Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2

  1999cited by this paper
• Cooperation Between Transcription Factor AP-1 and NF-kappa B in the Induction of Interleukin-8 in Human Pancreatic Adenocarcinoma Cells by Hypoxia

  1999cited by this paper
• Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System

  1999cited by this paper
• Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice.

  1999cited by this paper
• Adenovirus-mediated TNF-α Gene Transfer induces Significant Tumor Regression in Mice

  1999cited by this paper
• Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.

  1999cited by this paper
• Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

  1998cited by this paper
• Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin‐1α stimulation

  1998cited by this paper
• The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

  1998cited by this paper
• Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells

  1998cited by this paper
• Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.

  1998cited by this paper
• Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.

  1998cited by this paper
• Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.

  1998cited by this paper
• Involvement of matrix metalloproteinase‐2 activity in invasion and metastasis of pancreatic carcinoma

  1998cited by this paper
• Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

  1997cited by this paper
• Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth.

  1997cited by this paper
• Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes.

  1997cited by this paper
• IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences.

  1997cited by this paper
• Advances in the diagnosis and treatment of adenocarcinoma of the pancreas.

  1997cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• Management of patients with carcinoma of the pancreas.

  1996cited by this paper
• Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine.

  1996cited by this paper
• Pancreatic carcinoma in perspective: A continuing challenge

  1996cited by this paper
• Management of patients with carcinoma of the pancreas.

  1995cited by this paper
• The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

  1995cited by this paper
• Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration.

  1995cited by this paper
• Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors

  1995cited by this paper
• A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.

  1994cited by this paper
• Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.

  1994cited by this paper
• Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines.

  1994cited by this paper
• The origin and function of tumor-associated macrophages.

  1992cited by this paper
• Chemotactic factors, passive invasion and metastasis of cancer cells.

  1992cited by this paper
• Suppression of tumor formation in vivo by expression of the JE gene in malignant cells

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Introduction and overview

  1988cited by this paper
• Regulation of the macrophage content of neoplasms by chemoattractants.

  1983influential reference
• A continuing challenge

  1983cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• [Surgical therapy of pancreatic cancer].

  1952cited by this paper

• CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review)

  2025cites this paper
• Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma.

  2025cites this paper
• Inhibition of MCP1 (CCL2) Enhances Antitumor Activity of NK Cells Against HCC Cells Under Hypoxia

  2025cites this paper
• Overcoming solid-tumor barriers: armored CAR-T cell therapy.

  2025cites this paper
• Impact of senescent fibroblasts secretome in ovarian cancer dissemination.

  2025cites this paper
• Chemokine (C-C Motif) Ligand 2/CCR2/Extracellular Signal-Regulated Kinase Signal Induced through Cancer Cell–Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression

  2025cites this paper
• Evaluation of Serum Level of Chemokine (C-C Motif) Ligand 2 (CCL2) in Canine Urothelial Carcinomas, Mast Cell Tumours, and Insulinomas, and Its Correlation With Circulating Monocytes.

  2025cites this paper
• Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis

  2025cites this paper
• RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release

  2025cites this paper
• Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment

  2025cites this paper
• Oncolytic Tanapoxvirus Variants Expressing mIL-2 and mCCL-2 Regress Human Pancreatic Cancer Xenografts in Nude Mice

  2024cites this paper
• The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets

  2024cites this paper
• TGFβ2 Promotes the Construction of Fibrotic and Immunosuppressive Tumor Microenvironment in Pancreatic Adenocarcinoma: A Comprehensive Analysis

  2024cites this paper
• Monocyte and Macrophage Functions in Oncogenic Viral Infections

  2024cites this paper
• Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation

  2024cites this paper
• The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma

  2024influential citation
• Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma

  2024cites this paper
• Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)

  2024cites this paper
• Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges

  2023cites this paper
• Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer

  2023cites this paper
• Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers.

  2023cites this paper
• Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

  2023influential citation
• CDYL knockdown reduces glioma development through an antitumor immune response in the tumor microenvironment.

  2023cites this paper
• Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome

  2023cites this paper
• Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine

  2023cites this paper
• The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy

  2022cites this paper
• Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

  2022cites this paper
• MCP-1 facilitates VEGF production by removing miR-374b-5p blocking of VEGF mRNA translation.

  2022cites this paper
• Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Chemokine CCL2 and Its Receptor CCR2 in Regulation of Cognitive Functions and in Development of Aging Diseases

  2022cites this paper
• CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer.

  2022cites this paper
• NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1

  2022cites this paper
• Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS

  2022cites this paper
• Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells

  2022cites this paper
• Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma

  2022cites this paper
• Multifaceted role of chemokines in solid tumors: from biology to therapy.

  2021cites this paper
• Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

  2021cites this paper
• Myeloid Immune Cells CARrying a New Weapon Against Cancer

  2021cites this paper
• Purification of recombinant human chemokine CCL2 in E. coli and its function in ovarian cancer

  2021cites this paper
• Predictive Role of CC-Chemokine Ligand 2 in Digestive System Cancers: A Meta-Analysis

  2021cites this paper
• Association between post-treatment circulating biomarkers of inflammation and survival among stage II–III colorectal cancer patients

  2021cites this paper
• MCP-1: Function, regulation, and involvement in disease

  2021cites this paper
• Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment Through Fibroblast Reprogramming

  2021cites this paper
• Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?

  2021cites this paper
• Systemic Reprogramming of Monocytes in Cancer

  2020cites this paper
• Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?

  2020cites this paper
• Serum level of CCL2 predicts outcome of patients with pancreatic cancer.

  2020cites this paper
• Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?

  2020cites this paper
• CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage

  2020influential citation
• Regulation and modulation of antitumor immunity in pancreatic cancer

  2020cites this paper
• Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma

  2020cites this paper
• Prospective Anticancer Therapy for CCL2-CCR2 Pathway Inhibition using Propagermanium

  2020cites this paper
• Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?

  2020cites this paper
• Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes

  2020cites this paper
• Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.

  2020cites this paper
• MST1R Kinase Accelerates Pancreatic Cancer Progression Via Effects on both Epithelial Cells and Macrophages

  2019cites this paper
• MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis

  2019cites this paper
• Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients

  2019cites this paper
• CCL2 is associated with metastasis and poor prognosis of bladder cancer

  2019cites this paper
• Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells

  2019cites this paper
• RelB regulates basal and proinflammatory induction of conjunctival CCL2

  2019cites this paper
• TAMing pancreatic cancer: combat with a double edged sword

  2019cites this paper
• Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma

  2019cites this paper
• Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis.

  2019cites this paper
• Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents

  2019cites this paper
• Lipopolysaccharide and palmitic acid synergistically induced MCP-1 production via MAPK-meditated TLR4 signaling pathway in RAW264.7 cells

  2019cites this paper
• Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma

  2018cites this paper
• A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma

  2018cites this paper
• A pilot study investigating specific immune regulatory cells and microRNA in patients with advanced Pancreatic Adenocarcinoma treated with intravenous omega-3 fish oil infusion and Gemcitabine

  2018cites this paper
• Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients

  2018cites this paper
• Evaluation of urinary and serum level of chemokine (C‐C motif) ligand 2 as a potential biomarker in canine urothelial tumours

  2018cites this paper
• MONOCYTE CHEMOATTRACTANT PROTEIN-1 ( MCP-1 ) IS ASSOCIATED WITH PANCREATIC BETA-CELL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS BY

  2018cites this paper
• The regulation and importance of monocyte chemoattractant protein-1

  2018cites this paper
• Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma

  2018cites this paper
• A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women

  2018cites this paper
• Suppressed CCL2 expression inhibits the proliferation of leukemia cells via the cell cycle protein Cyclin D1: preliminary in vitro data.

  2018cites this paper
• The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.

  2018cites this paper
• Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts

  2018cites this paper
• CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer.

  2017cites this paper
• Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications

  2017cites this paper
• Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

  2017cites this paper
• Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.

  2017cites this paper
• Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma.

  2017cites this paper
• T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors

  2017cites this paper
• The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells

  2017cites this paper
• The role of human bone marrow mesenchymal stromal cells in pancreatic cancer growth

  2017cites this paper
• 3q26‐29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes

  2017cites this paper
• Identification of effective new drugs combinations exploiting the ability of trabectedin to modulate transcription

  2017cites this paper
• Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers

  2017cites this paper
• The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis.

  2017cites this paper
• Targeting the CCL2-CCR2 signaling axis in cancer metastasis

  2016cites this paper
• Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy

  2016cites this paper
• Exploring the immune environment of pancreatic ductal adenocarcinoma

  2016cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• Process of hepatic metastasis from pancreatic cancer: biology with clinical significance

  2016cites this paper
• Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.

  2016cites this paper
• Targeting tumor-associated macrophages to combat pancreatic cancer

  2016cites this paper
• CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma

  2016cites this paper
• APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice

  2016cites this paper